The chemical class of GMPR2 Inhibitors represents a diverse array of compounds that can influence the activity of Guanosine Monophosphate Reductase 2 (GMPR2), an enzyme pivotal in nucleotide metabolism. This class includes molecules that indirectly affect GMPR2's function by targeting various stages of purine and nucleotide metabolism. GMPR2, responsible for the conversion of GMP to IMP, plays a crucial role in maintaining the balance of nucleotide pools within cells, a process essential for numerous cellular activities including DNA synthesis, repair, and RNA transcription. The inhibitors in this class, through their distinct mechanisms, modulate this balance, thereby influencing GMPR2's activity.
The primary action of these inhibitors centers around altering the availability of substrates or intermediates necessary for GMPR2's catalytic activity. This modulation occurs through various pathways: some compounds affect the synthesis of purine nucleotides, thereby altering the pool of substrates available for GMPR2. Others influence the catabolism of purines, impacting the levels of nucleotides and their intermediates, which in turn can affect the enzymatic demand for GMPR2. Additionally, certain inhibitors in this class act by modulating the levels of other nucleotides, thereby indirectly influencing the balance of GMP and IMP within the cell. This indirect method of inhibition highlights the interconnected nature of nucleotide metabolism pathways and the reliance of GMPR2 on the dynamic equilibrium of these pathways. Furthermore, the role of GMPR2 inhibitors extends beyond the mere modulation of GMP and IMP levels. By influencing the overall nucleotide metabolism, these inhibitors can impact broader cellular processes that depend on adequate nucleotide pools. The diversity in their chemical structures and the breadth of their target pathways underscore the complex interplay between nucleotide synthesis, breakdown, and recycling, highlighting the multifaceted nature of GMPR2's role in cellular metabolism. Understanding the impact of these inhibitors on GMPR2 and related pathways enhances our comprehension of the intricate network of reactions involved in nucleotide homeostasis and the delicate balance maintained within cellular systems. In summary, GMPR2 inhibitors represent a significant class of compounds with the potential to modulate the activity of GMPR2 and thereby influence key metabolic pathways in cells. Their ability to interact with nucleotide metabolism processes positions them as important modulators of cellular homeostasis and stress response mechanisms. The study of these inhibitors offers valuable insights into the regulation of nucleotide pools and the critical role of GMPR2 in maintaining cellular equilibrium.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Inhibits IMP dehydrogenase, leading to decreased IMP and increased GMP levels; this feedback could potentially inhibit GMPR2 by altering its substrate dynamics. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
Acts as a nucleoside analog; disrupts nucleotide synthesis and could inhibit GMPR2 by unbalancing the nucleotide pools, thereby affecting its enzymatic activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase, affecting purine synthesis; could inhibit GMPR2 by reducing the availability of nucleotide precursors, impacting its substrate levels. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $199.00 $173.00 $342.00 $495.00 $690.00 | 1 | |
Prodrug for 6-mercaptopurine; impairs purine synthesis, potentially inhibiting GMPR2 by decreasing the overall pool of purine nucleotides. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $128.00 | ||
Xanthine oxidase inhibitor, affects purine catabolism; could inhibit GMPR2 by altering purine breakdown, indirectly affecting GMP levels. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $71.00 $102.00 | ||
Purine analog; disrupts de novo purine synthesis, potentially inhibiting GMPR2 by reducing the synthesis and availability of its substrates. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $41.00 $53.00 | 3 | |
Purine analog, affects nucleotide synthesis; could inhibit GMPR2 by competing with natural substrates and disrupting purine nucleotide levels. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Inhibits ribonucleotide reductase; could inhibit GMPR2 by altering the balance of ribonucleotide and deoxyribonucleotide pools, indirectly impacting GMP levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Inhibits thymidylate synthase; could inhibit GMPR2 by disrupting pyrimidine synthesis, indirectly affecting purine metabolism and GMP levels. | ||||||
Tiazofurin | 60084-10-8 | sc-475805 | 5 mg | $440.00 | ||
Inhibits IMP dehydrogenase; could inhibit GMPR2 by increasing GMP levels and disrupting the normal feedback mechanisms in nucleotide metabolism. | ||||||